Histidyl-Proline Diketopiperazine Isomers As Multipotent Anti-Alzheimer Drug Candidates
Overview
Molecular Biology
Authors
Affiliations
Cyclic dipeptides administered by both parenteral and oral routes are suggested as promising candidates for the treatment of neurodegeneration-related pathologies. In this study, we tested Cyclo (His-Pro) isomers (cHP1-4) for their anti-Alzheimer potential using a differentiated human neuroblastoma cell line (SH-SY5Y) as an Alzheimer's disease (AD) experimental model. The SH-SY5Y cell line was differentiated by the application of retinoic acid (RA) to obtain mature neuron-like cells. Amyloid-beta 1-42 () peptides, the main effector in AD, were administered to the differentiated cell cultures to constitute the in vitro disease model. Next, we performed cell viability analyses 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and lactate dehydrogenase (LDH) release assays) to investigate the neuroprotective concentrations of cyclodipeptides using the in vitro AD model. We evaluated acetylcholinesterase (AChE), α- and β-secretase activities (TACE and BACE1), antioxidant potency, and apoptotic/necrotic properties and performed global gene expression analysis to understand the main mechanism behind the neuroprotective features of cHP1-4. Moreover, we conducted sister chromatid exchange (SCE), micronucleus (MN), and 8-hydroxy-2'-deoxyguanosine (8-OHdG) analyses to evaluate the genotoxic damage potential after applications with cHP1-4 on cultured human lymphocytes. Our results revealed that cHP1-4 isomers provide a different degree of neuroprotection against -induced cell death on the in vitro AD model. The applications with cHP1-4 isomers altered the activity of AChE but not the activity of TACE and BACE1. Our analysis indicated that the cHP1-4 increased the total antioxidant capacity without altering total oxidative status levels in the cellular AD model and that cHP1-4 modulated the alterations of gene expressions by exposure. We also observed that cHP1-4 exhibited noncytotoxic and non-genotoxic features in cultured human whole blood cells. In conclusion, cHP1-4 isomers, especially cHP4, have been explored as novel promising therapeutics against AD.
Widodo W, Billerbeck S Eng Microbiol. 2024; 3(1):100067.
PMID: 39628525 PMC: 11610984. DOI: 10.1016/j.engmic.2022.100067.
Li X, Nong X, Yang J, Li M, Wang Q, Sun M Int J Mol Sci. 2024; 25(21).
PMID: 39518975 PMC: 11546255. DOI: 10.3390/ijms252111421.
Cyclodipeptide oxidase is an enzyme filament.
Andreas M, Giessen T Nat Commun. 2024; 15(1):3574.
PMID: 38678027 PMC: 11055893. DOI: 10.1038/s41467-024-48030-9.
Novel styryl-thiazole hybrids as potential anti-Alzheimer's agents.
Gouleni N, Di Rienzo A, Yilmaz A, Selvitopi H, Arslan M, Mardinoglu A RSC Med Chem. 2023; 14(11):2315-2326.
PMID: 38020070 PMC: 10650344. DOI: 10.1039/d3md00308f.
Turkez H, Tozlu O, Tatar A, Arslan M, Cadirci K, Marinelli L J Toxicol. 2022; 2022:3775194.
PMID: 36444193 PMC: 9701129. DOI: 10.1155/2022/3775194.